{"id":"W2161021913","doi":"10.3324/haematol.2014.115840","title":"Efficacy, safety, and survival with ruxolitinib in patients with myelofibrosis: results of a median 3-year follow-up of COMFORT-I","year":2015,"lang":"en","type":"article","venue":"Haematologica","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":329,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"Stanford Cancer Institute; National Heart, Lung, and Blood Institute; University of Texas MD Anderson Cancer Center; Weill Cornell Medical College; University of California, Los Angeles; Monash University; Hollings Cancer Center, Medical University of South Carolina; Northwestern University; Incyte; NIH Clinical Center; Townsville Hospital and Health Service; Emory University; Huntsman Cancer Institute; University of Toronto; Tower Cancer Research Foundation; London Health Sciences Centre; Barbara Ann Karmanos Cancer Institute; Rush University; University of Louisville; Georgetown University; National Cancer Institute; Wake Forest University; Kaiser Permanente; Cleveland Clinic; George Washington University; University of Pennsylvania; Vanderbilt University; University of Southern California; Park Nicollet Foundation","keywords":"Ruxolitinib; Myelofibrosis; Medicine; Internal medicine; Oncology; Surgery; Bone marrow","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00451913,0.0004675844,0.001246368,0.0002924864,0.0004416453,0.0008097046,0.0003460543,0.000757403,0.0008393311],"category_scores_gemma":[0.002925476,0.0001838477,0.001974226,0.0004613815,0.0003286729,0.0006471704,0.0004024095,0.001099172,0.0002548113],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005793281,"about_ca_system_score_gemma":0.0004683567,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006447558,"about_ca_topic_score_gemma":0.0009782293,"domain_scores_codex":[0.9989863,0.0004025004,0.000110274,0.0001484807,0.0002082717,0.0001440818],"domain_scores_gemma":[0.9975719,0.0005493705,0.0009473108,0.000218904,0.0002657121,0.0004468147],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.2325059,0.005882286,0.5836546,0.0005205753,0.003687802,0.0007084294,0.0005942368,0.003042882,0.01290603,0.0001133511,0.001564092,0.1548197],"study_design_scores_gemma":[0.00823939,0.08980159,0.8921694,0.00007524232,0.002384902,0.0006616196,0.0001676454,0.001532827,0.002829773,0.0001561267,0.001914294,0.00006722088],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9965114,0.002281863,0.0002021673,0.0001093809,0.00001134514,0.00005585898,0.0003320827,0.00001407183,0.0004817699],"genre_scores_gemma":[0.9983156,0.0003563304,0.0001788537,0.0001158481,0.00003054526,0.00003886486,0.0007612375,0.000002906093,0.000199779],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00451913,"threshold_uncertainty_score":0.02389973,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02592074123617636,"score_gpt":0.2561980427566157,"score_spread":0.2302773015204394,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}